The VA announced this month that it has received additional
funding from Congress for fiscal year 2016 that will make it possible to
provide care for all veterans who have Hepatitis C, regardless of the stage of
the disease.
Chronic Hepatitis C is the most common blood-borne infection in
the world, yet 75% of those infected don’t know it. Serious complications like
liver damage leading to cirrhosis, primary liver cancer, liver failure, or even
death can occur when Hepatitis C is left untreated.
Several new antiviral medications designed to treat Chronic
Hepatitis C received FDA approval in the past 2 years, and others are still in
clinical trials. These new medications are used in combination to treat
patients with ongoing or Chronic Hepatitis C by stopping the virus from
reproducing and spreading in the body. Different combinations may be used
depending on whether you have Hepatitis C genotype 1, 2, or 3. The length of
treatment can last from 12 weeks, for Types 1 or 2, to 24 weeks, for Type 3.
If you still show signs of the virus after your initial course
of treatment, a different combination may need to be used. As with all diseases
and treatments, these medications are more likely to be effective if you have a
low level of the virus in your blood stream and minimal liver damage when
treatment starts, however these new antivirals seem to work both with patients
who have never before been treated for their Hepatitis C as well as those whose
first course of treatment didn’t result in a cure.
There are more than 170,000 veterans in the VA Healthcare
system that have been diagnosed with Hepatitis C. To date, the VA has treated
more than 76,000 of them, resulting in over 60,000 cures. Since the beginning
of 2014, however, only 42,000 veterans have been treated with the new, more
effective antivirals due to budgetary restraints.
Last year, the VA budgeted $696,000 for the new Hepatitis C
drugs—over 17% of its total budget for medications—and anticipates that it will
need over $1,000,000 for those medications in 2016 in order to treat all veterans
who have been diagnosed. With the increased funding recently granted by
Congress, the VA now has the funds it needs to treat all veterans with
Hepatitis C, and the VA expects to see an increasing number of veterans
starting treatment each week.
With this expansion, veterans who are currently waiting for
an appointment with a civilian provider through the Choice Program can contact
their local VA facility to receive treatment for their Hepatitis C, or they can
choose to continue to be treated by a civilian provider. Visit the VA’s
Hepatitis C page for more information, http://www.hepatitis.va.gov/patient/hcv/index.asp.
No comments:
Post a Comment